MiniMed Group, Inc. Common Stock MMED
i
Market dataready · fetched 2026-11-04T04:14:48.475Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T21:01:08.780149691Z
FundamentalsSEC EDGAR · ready · as of 2026-07-31 · fetched 2026-11-04T04:14:48.055057+00:00
MiniMed Group, Inc. Common Stock options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 16.37 | 51.9% | 11.3% | |||
| 25Δ | 20.14 | 60.9% | 12.5% | 16.88 | 47.7% | 8.8% |
| 30Δ | 19.72 | 63.9% | 11.2% | 17.39 | 43.4% | 6.3% |
| 35Δ | 19.38 | 68.3% | 10.4% | |||
| 40Δ | 19.03 | 72.6% | 9.6% | |||
| 45Δ | 18.68 | 76.9% | 8.8% | |||
| 50Δ | 18.34 | 81.2% | 8.0% | |||
| 55Δ | 17.99 | 85.5% | 7.2% | |||
| 60Δ | 17.64 | 89.8% | 6.4% | |||
| 65Δ | 17.00 | 106.0% | 6.0% | |||
| 70Δ | 16.15 | 130.4% | 6.0% | |||
| 75Δ | 15.30 | 154.8% | 5.9% | |||
| 80Δ | 14.10 | 179.2% | 5.3% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 16.37
- IV
- 51.9%
- B/E move
- 11.3%
25Δ
- Pseudo strike
- 20.14
- IV
- 60.9%
- B/E move
- 12.5%
- Pseudo strike
- 16.88
- IV
- 47.7%
- B/E move
- 8.8%
30Δ
- Pseudo strike
- 19.72
- IV
- 63.9%
- B/E move
- 11.2%
- Pseudo strike
- 17.39
- IV
- 43.4%
- B/E move
- 6.3%
35Δ
- Pseudo strike
- 19.38
- IV
- 68.3%
- B/E move
- 10.4%
- Pseudo strike
- IV
- B/E move
40Δ
- Pseudo strike
- 19.03
- IV
- 72.6%
- B/E move
- 9.6%
- Pseudo strike
- IV
- B/E move
45Δ
- Pseudo strike
- 18.68
- IV
- 76.9%
- B/E move
- 8.8%
- Pseudo strike
- IV
- B/E move
50Δ
- Pseudo strike
- 18.34
- IV
- 81.2%
- B/E move
- 8.0%
- Pseudo strike
- IV
- B/E move
55Δ
- Pseudo strike
- 17.99
- IV
- 85.5%
- B/E move
- 7.2%
- Pseudo strike
- IV
- B/E move
60Δ
- Pseudo strike
- 17.64
- IV
- 89.8%
- B/E move
- 6.4%
- Pseudo strike
- IV
- B/E move
65Δ
- Pseudo strike
- 17.00
- IV
- 106.0%
- B/E move
- 6.0%
- Pseudo strike
- IV
- B/E move
70Δ
- Pseudo strike
- 16.15
- IV
- 130.4%
- B/E move
- 6.0%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 15.30
- IV
- 154.8%
- B/E move
- 5.9%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 14.10
- IV
- 179.2%
- B/E move
- 5.3%
- Pseudo strike
- IV
- B/E move
Options history
Table
| Date | IV (%) |
|---|---|
| 68.37% | |
| 75.75% | |
| 70.23% | |
| 66.98% | |
| 72.59% | |
| 78.89% | |
| 85.52% | |
| 96.62% | |
| 64.77% | |
| 69.89% | |
| 68.15% | |
| 66.56% | |
| 76.07% | |
| 71.61% | |
| 66.33% | |
| 58.39% | |
| 62.21% | |
| 58.59% | |
| 64.79% | |
| 63.30% | |
| 56.54% | |
| 64.17% | |
| 77.14% | |
| 68.66% | |
| 73.56% | |
| 66.59% | |
| 60.72% | |
| 66.20% | |
| 73.70% | |
| 65.64% | |
| 65.88% | |
| 67.07% | |
| 67.18% | |
| 74.29% | |
| 65.79% | |
| 69.28% | |
| 73.08% | |
| 58.75% | |
| 50.47% | |
| 49.53% | |
| 52.10% | |
| 50.62% | |
| 49.29% | |
| 51.53% | |
| 49.00% | |
| 50.84% | |
| 46.19% | |
| 57.04% |
Medical Instruments & Supplies
MMSI
Merit Medical Systems, Inc. manufactures and markets disposable medical devices for interventional, diagnostic, and therapeutic procedures in cardiology, radiology, oncology,…
More →NVST
Envista Holdings Corporation, develops, manufactures and markets dental products in the United States and internationally. The company is headquartered in Brea, California.
More →OSUR
OraSure Technologies, Inc. develops, manufactures, markets, and sells oral fluid diagnostic products and sample collection devices in the United States, Europe, and…
More →PLSE
Pulse Biosciences, Inc. is a bioelectrical medicine startup. The company is headquartered in Hayward, California.
More →RGEN
Repligen Corporation develops and markets bioprocessing systems and technologies for use in the biologic drug manufacturing process in North America, Europe, Asia Pacific, and…
More →RMD
Description unavailable
More →